Showing results (721-730 of 1,126) with videos related to
Sort By:
Pageof 113
Cancer Genetics|January 2, 2022
Is 5q deletion in de novo Acute Myelogenous Leukemia (AML) with excess blasts a surrogate marker for the cryptic t(7;21)(p22;q22)? A case report and review of literatureRobert D Johnston, Farzaneh H Sayedian, Christina Mendiola, et al.Cancer Genetics|October 26, 2022
Partial tandem duplication of KMT2A gene in patient afflicted with hypereosinophilic syndrome: A case reportFaramarz Ghasemian Sorbeni, Atefeh Ansarin, Ebrahim Sakhinia, et al.Cancer Genetics|October 24, 2022
Myxoid spindle cell sarcoma with ETV6-NTRK3 fusionAnastasios Kyriazoglou, Efhtymios Dimitriadis, Luiza Mahaira, et al.Cancer Genetics|September 20, 2022
Identification of BRIP1, NSMCE2, ANAPC7, RAD18 and TTL from chromosome segregation gene set associated with hepatocellular carcinomaCeren SucularliCancer Genetics|September 30, 2021
Selection for or against escape from nonsense mediated decay is a novel signature for the detection of cancer genesRunjun D Kumar, Briana A Burns, Paul J Vandeventer, et al.Cancer Genetics|February 26, 2022
Cancer risk among RECQL4 heterozygotesBailey A Martin-Giacalone, Ta-Tara Rideau, Michael E Scheurer, et al.Cancer Genetics|May 19, 2019
Outcomes of disease-specific next-generation sequencing gene panel testing in adolescents and young adults with colorectal cancerMaureen E Mork, Andrea Rodriguez, Sarah A Bannon, et al.Cancer Genetics|February 2, 2022
The promise of TRK inhibitors in pediatric cancers with NTRK fusionsEmily R Blauel, Theodore W LaetschCancer Genetics|March 30, 2022
Functional analysis of ATM variants in a high risk cohort provides insight into missing heritabilityScott L Baughan, Fatima Darwiche, Michael A TainskyCancer Genetics|March 15, 2022
NTRK-fusions in pediatric thyroid tumors: Current state and future perspectivesVictoria Casado-Medrano, Alison O'Neill, Stephen Halada, et al.Pageof 113